Back to top
more

Inogen (INGN)

(Delayed Data from NSDQ)

$7.97 USD

7.97
153,580

+0.20 (2.57%)

Updated Jun 27, 2024 04:00 PM ET

After-Market: $7.95 -0.02 (-0.25%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (169 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for INGN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Inogen, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 128 187 246 231 209
Receivables 43 64 26 32 37
Notes Receivable 0 0 0 0 0
Inventories 22 34 32 25 36
Other Current Assets 14 19 26 18 10
Total Current Assets 207 305 329 306 292
Net Property & Equipment 50 43 39 28 19
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 14 14
Intangibles 45 33 93 102 110
Deposits & Other Assets 4 2 3 3 5
Total Assets 326 405 490 462 447
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 30 34 26 34 31
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 11 11 17 7 6
Income Taxes Payable 0 0 0 1 1
Other Current Liabilities 28 17 15 13 10
Total Current Liabilities 73 65 62 57 50
Mortgages 0 0 0 0 0
Deferred Taxes/Income 17 10 12 12 14
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 14 12 23 36 34
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 121 108 119 112 103
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 321 312 299 274 263
Retained Earnings -117 -15 69 76 81
Other Equity 1 0 1 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 205 297 370 350 345
Total Liabilities & Shareholder's Equity 326 405 490 462 447
Total Common Equity 205 297 370 350 345
Shares Outstanding 23.30 22.90 22.70 22.10 22.00
Book Value Per Share 8.79 12.99 16.31 15.82 15.66

Fiscal Year End for Inogen, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 120 128 138 170 175
Receivables 41 43 49 53 56
Notes Receivable 0 0 0 0 0
Inventories 25 22 24 31 39
Other Current Assets 14 14 14 15 14
Total Current Assets 199 207 225 269 283
Net Property & Equipment 49 50 50 49 46
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 43 45 44 33 33
Deposits & Other Assets 4 4 4 3 3
Total Assets 316 326 344 374 386
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 32 30 30 28 32
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 11 11 8 11 11
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 28 28 18 17 17
Total Current Liabilities 74 73 60 59 63
Mortgages 0 0 0 0 0
Deferred Taxes/Income 16 17 17 9 10
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 15 17 13 12
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 124 121 113 100 104
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 323 321 322 319 316
Retained Earnings -132 -117 -90 -45 -35
Other Equity 0 1 -1 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 192 205 231 275 281
Total Liabilities & Shareholder's Equity 316 326 344 374 386
Total Common Equity 192 205 231 275 281
Shares Outstanding 23.50 23.30 23.10 23.10 23.10
Book Value Per Share 8.17 8.79 9.98 11.90 12.18